🎙️ Episode 32: SGLT2 vs Kidney Stones: A Surprising Win

Brilliant Board Review & CME
20/04/2025 3 min Temporada 1 Episodio 32
🎙️ Episode 32: SGLT2 vs Kidney Stones: A Surprising Win

Listen "🎙️ Episode 32: SGLT2 vs Kidney Stones: A Surprising Win"

Descargar episodio

Episode Synopsis

Send us a text🧪 Key Findings:Cohort study: SGLT2 inhibitors led to significantly lower rates of nephrolithiasis compared to GLP-1 RAs.Mechanism: increased urinary flow and uric acid excretion.🔢 Stats:NNT = 20 for prevention.NNT = 5 for recurrent stone formers.🧩 Clinical Takeaway:Another bonus benefit of SGLT2 inhibitors.May sway decision in diabetics prone to stones.HCTZ no longer holds the same weight in stone prevention.

More episodes of the podcast Brilliant Board Review & CME

🎙️ Episode 45: Mind the Gap – Perioperative Pearls for Older Adults 21/04/2025
🎙️ Episode 44: Thiazide Throwdown: HCTZ vs Chlorthalidone in Real Life 21/04/2025
🎙️ Episode 43: GLP-1s Under the Knife – A Gut Check on Surgery Risks 21/04/2025
🎙️ Episode 42: DOACs Decoded: When to Dabble, When to Dodge 21/04/2025
🎙️ Episode 41: Stairway to Surgery: Cardiac Clues Before the Cut 21/04/2025
🎙️ Episode 40: Anticoag After Ischemic Stroke: Sooner May Be Safer 20/04/2025
🎙️ Episode 39: Vitamin K2: The Leg Cramp Secret? 20/04/2025
🎙️ Episode 38: TXA for ICH: Not the Magic Bullet 20/04/2025
🎙️ Episode 37: Transfusions in SAH: 8 or 10? Pick 8 20/04/2025
🎙️ Episode 36: Mitral Valve 2.0: Transcatheter Repair Steps Up 20/04/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA